![](/img/cover-not-exists.png)
Double-blind efficacy and safety study of a novel anti-ischemic agent, ranolazine, versus placebo in patients with chronic stable angina pectoris. Ranolazine Study Group
Thadani, U., Ezekowitz, M., Fenney, L., Chiang, Y. K.Volume:
90
Language:
english
Journal:
Circulation
DOI:
10.1161/01.cir.90.2.726
Date:
August, 1994
File:
PDF, 1.87 MB
english, 1994